15 Biologics are Going off Patent (2025–2029)
12 June 2025 Category: Drug DevelopmentGlobal biologics sales crossed $411 billion in 2024, with top-performing therapies treating cancer, autoimmune disorders, and rare diseases.
Global biologics sales crossed $411 billion in 2024, with top-performing therapies treating cancer, autoimmune disorders, and rare diseases.
The design and development of orphan drugs, designed for rare diseases, are uniquely challenged as limited patient populations available for clinical trials.
Harnessing continuous data to accelerate clinical discovery, driving innovation with real-time insights and transformative solutions for healthcare breakthroughs.
Explore how digital tools are transforming patient engagement in cardiometabolic trials, enhancing recruitment, retention, and real-world data collection.
Exploring the benefits, challenges, and role play in medical innovation and patient care.